These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9627935)

  • 1. A simplified vaccinologists' vaccinology and the pursuit of a vaccine against AIDS.
    Hilleman MR
    Vaccine; 1998 May; 16(8):778-93. PubMed ID: 9627935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disappointing data scuttle plans for large-scale AIDS vaccine trial.
    Cohen J
    Science; 2002 Mar; 295(5560):1616-7. PubMed ID: 11872804
    [No Abstract]   [Full Text] [Related]  

  • 3. AIDS vaccine shows promise after years of frustration.
    Cohen J
    Science; 2001 Mar; 291(5509):1686-8. PubMed ID: 11263450
    [No Abstract]   [Full Text] [Related]  

  • 4. Vaccinology, immunology, and comparative pathogenesis of measles in the quest for a preventative against AIDS.
    Hilleman MR
    AIDS Res Hum Retroviruses; 1994 Jan; 10(1):3-12. PubMed ID: 8179962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a multicomponent candidate vaccine for HIV-1.
    Kim JJ; Ayyavoo V; Bagarazzi ML; Chattergoon M; Boyer JD; Wang B; Weiner DB
    Vaccine; 1997 Jun; 15(8):879-83. PubMed ID: 9234538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quest for an effective AIDS vaccine takes a new tack.
    Maurice J
    Lancet; 2011 Jul; 378(9787):213-4. PubMed ID: 21770060
    [No Abstract]   [Full Text] [Related]  

  • 7. AIDS vaccine development.
    Lévy JP
    Science; 1998 May; 280(5365):806-7. PubMed ID: 9599149
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunology. New virtual center aims to speed AIDS vaccine progress.
    Cohen J
    Science; 2005 Jul; 309(5734):541. PubMed ID: 16040673
    [No Abstract]   [Full Text] [Related]  

  • 9. Introduction: Back to basics: mucosal immunity and novel HIV vaccine concepts.
    Broliden K; Haase AT; Ahuja SK; Shearer GM; Andersson J
    J Intern Med; 2009 Jan; 265(1):5-17. PubMed ID: 19093956
    [No Abstract]   [Full Text] [Related]  

  • 10. Is an effective HIV vaccine feasible?
    Cohen J
    Science; 2005 Jul; 309(5731):99. PubMed ID: 15994545
    [No Abstract]   [Full Text] [Related]  

  • 11. Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model.
    Nehete PN; Chitta S; Hossain MM; Hill L; Bernacky BJ; Baze W; Arlinghaus RB; Sastry KJ
    Vaccine; 2001 Dec; 20(5-6):813-25. PubMed ID: 11738745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New gene-based approaches for an AIDS vaccine.
    Puaux AL; Michel ML
    Comp Immunol Microbiol Infect Dis; 2003 Oct; 26(5-6):357-72. PubMed ID: 12818622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunology and the elusive AIDS vaccine.
    Virgin HW; Walker BD
    Nature; 2010 Mar; 464(7286):224-31. PubMed ID: 20220841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A noninfectious simian/human immunodeficiency virus DNA vaccine that protects macaques against AIDS.
    Singh DK; Liu Z; Sheffer D; Mackay GA; Smith M; Dhillon S; Hegde R; Jia F; Adany I; Narayan O
    J Virol; 2005 Mar; 79(6):3419-28. PubMed ID: 15731236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal immunization with a DNA vaccine induces immune responses against HIV-1 at a mucosal site.
    Wang B; Dang K; Agadjanyan MG; Srikantan V; Li F; Ugen KE; Boyer J; Merva M; Williams WV; Weiner DB
    Vaccine; 1997 Jun; 15(8):821-5. PubMed ID: 9234524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prime-boost strategies in DNA vaccines.
    Dale CJ; Thomson S; De Rose R; Ranasinghe C; Medveczky CJ; Pamungkas J; Boyle DB; Ramshaw IA; Kent SJ
    Methods Mol Med; 2006; 127():171-97. PubMed ID: 16988455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An HIV type 2 DNA vaccine induces cross-reactive immune responses against HIV type 2 and SIV.
    Agadjanyan MG; Trivedi NN; Kudchodkar S; Bennett M; Levine W; Lin A; Boyer J; Levy D; Ugen KE; Kim JJ; Weiner DB
    AIDS Res Hum Retroviruses; 1997 Dec; 13(18):1561-72. PubMed ID: 9430248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immune response to HIV: implications for vaccine development.
    Bolognesi DP
    Semin Immunol; 1993 Jun; 5(3):203-14. PubMed ID: 8347841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.
    Amara RR; Villinger F; Altman JD; Lydy SL; O'Neil SP; Staprans SI; Montefiori DC; Xu Y; Herndon JG; Wyatt LS; Candido MA; Kozyr NL; Earl PL; Smith JM; Ma HL; Grimm BD; Hulsey ML; Miller J; McClure HM; McNicholl JM; Moss B; Robinson HL
    Science; 2001 Apr; 292(5514):69-74. PubMed ID: 11393868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subtype C gp140 Vaccine Boosts Immune Responses Primed by the South African AIDS Vaccine Initiative DNA-C2 and MVA-C HIV Vaccines after More than a 2-Year Gap.
    Gray GE; Mayer KH; Elizaga ML; Bekker LG; Allen M; Morris L; Montefiori D; De Rosa SC; Sato A; Gu N; Tomaras GD; Tucker T; Barnett SW; Mkhize NN; Shen X; Downing K; Williamson C; Pensiero M; Corey L; Williamson AL
    Clin Vaccine Immunol; 2016 Jun; 23(6):496-506. PubMed ID: 27098021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.